Skip to main content

Find Clinical Trials

Home
Conditions
RSV Immunization

Clinical trial condition

RSV Immunization

Explore clinical trials studying RSV Immunization. Study availability and eligibility vary by location and protocol.

9 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

RSV Immunization trial results

Recruiting

An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During Their First RSV Season in the Czechia

NCT07634692

Conditions: RSV Immunization
Locations: Sanofi s.r.o. Prague, Czechia

View Trial Details

Recruiting

RSV Immunisation Status in Queensland (Australia)

NCT07615192

Conditions: RSV Immunization
Locations: Paratus Clinical Research Brisbane, Queensland, Australia

View Trial Details

Recruiting

Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination

NCT07232706

Conditions: Infections, RSV Immunization, Respiratory Tract Diseases, +1 more
Locations: CHD Vendée La Roche-sur-Yon, France

View Trial Details

Recruiting

A Study to Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults

NCT07171164

Conditions: Older Adults Without Any Specific Clinical Condition, RSV Immunization, Social Networks, +1 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Not Yet Recruiting

Study of HIV-Exposed Pregnancies and Transplacental Antibody Delivery Following RSVpreF

NCT07693166

Conditions: HIV, RSV Immunization
Locations: Not specified

View Trial Details

Not Yet Recruiting

RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients

NCT07296120

Conditions: Bone Marrow Transplant - Autologous or Allogeneic, CAR-T Cell Therapy, RSV Immunization
Locations: Cooper University Hospital Camden, New Jersey, United States

View Trial Details

Not Yet Recruiting

Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination.

NCT07041190

Conditions: RSV Immunization
Locations: Not specified

View Trial Details

Completed

Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life

NCT05437510

Conditions: Healthy Volunteer, RSV Immunization
Locations: Investigational Site 2500041 Aix-en-Provence, France

Investigational Site 2500002 Amiens, France

Investigational Site Number: 2500014 Bordeaux, France

Investigational Site 2500007 Brest, France

View all 240 locations

View Trial Details

Active, Not Recruiting

Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India

NCT07109297

Conditions: RSV Immunization
Locations: Investigational Site Number : 3560002 Bengaluru, India

Investigational Site Number : 3560008 Jaipur, India

Investigational Site Number : 3560003 Kolkata, India

Investigational Site Number : 3560007 Nagpur, India

View Trial Details